Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis.

Acquaviva M, Bassani C, Sarno N, Dalla Costa G, Romeo M, Sangalli F, Colombo B, Moiola L, Martinelli V, Comi G, Farina C.

Front Immunol. 2019 Aug 14;10:1922. doi: 10.3389/fimmu.2019.01922. eCollection 2019.

2.

Reply to "Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy".

Dalla Costa G, Martinelli V, Furlan R, Comi G.

Ann Neurol. 2019 Aug;86(2):324. doi: 10.1002/ana.25526. Epub 2019 Jun 26. No abstract available.

PMID:
31187511
3.

Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis.

Dalla Costa G, Romeo M, Esposito F, Sangalli F, Colombo B, Radaelli M, Moiola L, Comi G, Martinelli V.

Mult Scler Relat Disord. 2019 Aug;33:75-77. doi: 10.1016/j.msard.2019.05.010. Epub 2019 May 21.

PMID:
31158806
4.

Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data.

Giordano A, Vabanesi M, Dalla Costa G, Cerri F, Comi G, Martinelli V, Fazio R.

Neurol Sci. 2019 May;40(5):1015-1018. doi: 10.1007/s10072-019-03757-y. Epub 2019 Feb 14.

PMID:
30762168
5.

Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients.

Dalla Costa G, Martinelli V, Moiola L, Sangalli F, Colombo B, Finardi A, Cinque P, Kolb EM, Haghikia A, Gold R, Furlan R, Comi G.

Ann Neurol. 2019 Apr;85(4):606-610. doi: 10.1002/ana.25437. Epub 2019 Mar 5.

PMID:
30761586
6.

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes.

Dalla Costa G, Martinelli V, Sangalli F, Moiola L, Colombo B, Radaelli M, Leocani L, Furlan R, Comi G.

Neurology. 2019 Feb 12;92(7):e733-e741. doi: 10.1212/WNL.0000000000006902. Epub 2019 Jan 11.

7.

Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation.

Martinelli V, Dalla Costa G, Sangalli F, Colombo B, Robotti M, Moiola L, Comi G.

Mult Scler Relat Disord. 2019 Feb;28:57-59. doi: 10.1016/j.msard.2018.11.034. Epub 2018 Dec 1.

PMID:
30554038
8.

Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.

Romeo MAL, Martinelli V, Dalla Costa G, Colombo B, De Feo D, Esposito F, Ferrè L, Guaschino C, Guerrieri S, Liberatore G, Martinelli Boneschi F, Merlini A, Messina M, Messina R, Nuara A, Preziosa P, Radaelli M, Rocca MA, Rodegher M, Sangalli F, Strambo D, Moiola L, Comi G.

Acta Neurol Scand. 2018 Nov;138(5):447-453. doi: 10.1111/ane.12999. Epub 2018 Jul 22.

PMID:
30033621
9.

Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.

Ferre' L, Clarelli F, Sferruzza G, Rocca MA, Mascia E, Radaelli M, Sangalli F, Dalla Costa G, Moiola L, Aboulwafa M, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V, Esposito F.

Neurol Sci. 2018 Aug;39(8):1467-1470. doi: 10.1007/s10072-018-3440-0. Epub 2018 May 13.

PMID:
29756179
10.

Digital epidemiology confirms a latitude gradient of MS in France.

Dalla Costa G, Giordano A, Romeo M, Sangalli F, Comi G, Martinelli V.

Mult Scler Relat Disord. 2018 Feb;20:129-131. doi: 10.1016/j.msard.2018.01.009. Epub 2018 Mar 20.

PMID:
29414285
11.

Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice.

Dalla-Costa G, Radaelli M, Maida S, Sangalli F, Colombo B, Moiola L, Comi G, Martinelli V.

J Neurol Sci. 2017 Dec 15;383:166-168. doi: 10.1016/j.jns.2017.10.043. Epub 2017 Oct 27.

PMID:
29246607
12.

Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients.

Dalla Costa G, Finardi A, Garzetti L, Carandini T, Comi G, Martinelli V, Furlan R.

Neurol Sci. 2018 Feb;39(2):373-376. doi: 10.1007/s10072-017-3176-2. Epub 2017 Nov 28.

PMID:
29185135
13.

High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis.

Cosorich I, Dalla-Costa G, Sorini C, Ferrarese R, Messina MJ, Dolpady J, Radice E, Mariani A, Testoni PA, Canducci F, Comi G, Martinelli V, Falcone M.

Sci Adv. 2017 Jul 12;3(7):e1700492. doi: 10.1126/sciadv.1700492. eCollection 2017 Jul.

14.

Letter re: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Dalla Costa G, Martinelli V, Comi G.

Neurology. 2017 May 23;88(21):2067. doi: 10.1212/WNL.0000000000003972. No abstract available.

PMID:
28533348
15.

Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes.

Martinelli V, Dalla Costa G, Messina MJ, Di Maggio G, Sangalli F, Moiola L, Rodegher M, Colombo B, Furlan R, Leocani L, Falini A, Comi G.

Acta Neurol Scand. 2017 Nov;136(5):454-461. doi: 10.1111/ane.12761. Epub 2017 Apr 9.

PMID:
28393349
16.

Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis.

Passerini G, Dalla Costa G, Sangalli F, Moiola L, Colombo B, Locatelli M, Comi G, Furlan R, Martinelli V.

Mult Scler Int. 2016;2016:2303857. doi: 10.1155/2016/2303857. Epub 2016 Dec 28.

17.

Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection.

Martinelli V, Dalla Costa G, Moiola L, Pavan G, Diotti RA, De Riz MA, Gerevini S, Comi G.

Eur J Neurol. 2016 Jul;23(7):e39-40. doi: 10.1111/ene.13027. No abstract available.

PMID:
27272110
18.

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective.

Messina MJ, Dalla Costa G, Rodegher M, Moiola L, Colombo B, Comi G, Martinelli V.

Mult Scler Int. 2015;2015:353828. doi: 10.1155/2015/353828. Epub 2015 Dec 15.

19.

Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes.

Dalla Costa G, Passerini G, Messina MJ, Moiola L, Rodegher M, Colombo B, Locatelli M, Comi G, Furlan R, Martinelli V.

J Neuroimmunol. 2015 Dec 15;289:62-7. doi: 10.1016/j.jneuroim.2015.10.009. Epub 2015 Oct 19.

PMID:
26616872
20.

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.

Disanto G, Adiutori R, Dobson R, Martinelli V, Dalla Costa G, Runia T, Evdoshenko E, Thouvenot E, Trojano M, Norgren N, Teunissen C, Kappos L, Giovannoni G, Kuhle J; International Clinically Isolated Syndrome Study Group.

J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):126-9. doi: 10.1136/jnnp-2014-309690. Epub 2015 Feb 25.

PMID:
25716934
21.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Dalla Costa G, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeño JC, Kleinová P, Horáková D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martínez AD, Carra A, Salvetti M, Uccelli A, Torkildsen Ø, Myhr KM, Galimberti D, Rejdak K, Lycke J, Frederiksen JL, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli Ö, Vécsei L, Kieseier BC, Hartung HP, Villoslada P, Siva A, Saiz A, Tumani H, Havrdová E, Villar LM, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintoré M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan SV, Giovannoni G.

Mult Scler. 2015 Jul;21(8):1013-24. doi: 10.1177/1352458514568827. Epub 2015 Feb 13.

PMID:
25680984
22.

Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey.

Maida S, Dalla Costa G, Rodegher M, Falautano M, Comi G, Martinelli V.

Clin Trials. 2014 Dec;11(6):667-72. doi: 10.1177/1740774514545248. Epub 2014 Aug 3.

PMID:
25092808
23.

Opinion & special articles: professionalism in neurology. Maintaining patient rapport in a world of EMR.

Dalla Costa G, Maida S, Sorrentino P, Braunstein M, Comi G, Martinelli V.

Neurology. 2014 Jul 8;83(2):e12-5. doi: 10.1212/WNL.0000000000000569. No abstract available.

PMID:
25002570
24.

Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.

Martinelli V, Dalla Costa G, Colombo B, Dalla Libera D, Rubinacci A, Filippi M, Furlan R, Comi G.

Mult Scler. 2014 Feb;20(2):147-55. doi: 10.1177/1352458513494959. Epub 2013 Jul 8.

PMID:
23836877
25.

Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.

Martinelli V, Colombo B, Dalla Costa G, Dalla Libera D, Moiola L, Falini A, Comi G, Filippi M.

Mult Scler. 2016 Oct;22(11):1506-1508. Epub 2013 Jun 17. No abstract available.

PMID:
23773984
26.

Refractory migraine: the role of the physician in assessment and treatment of a problematic disease.

Colombo B, Dalla Libera D, Dalla Costa G, Comi G.

Neurol Sci. 2013 May;34 Suppl 1:S109-12. doi: 10.1007/s10072-013-1385-x.

PMID:
23695056
27.

Parry Romberg syndrome associated with chronic facial pain.

Dalla Costa G, Colombo B, Dalla Libera D, Martinelli V, Comi G.

J Clin Neurosci. 2013 Sep;20(9):1320-2. doi: 10.1016/j.jocn.2012.08.020. Epub 2013 Mar 22.

PMID:
23528409
28.

Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy.

Colombo B, Dalla Libera D, Volontè MA, Spagnolo F, Dalla Costa G, Martinelli V, Comi G.

Neurol Sci. 2013 Aug;34(8):1465-6. doi: 10.1007/s10072-012-1212-9. Epub 2012 Nov 3. No abstract available.

PMID:
23124486
29.

From neuroimaging to clinical setting: what have we learned from migraine pain?

Colombo B, Dalla Costa G, Dalla Libera D, Comi G.

Neurol Sci. 2012 May;33 Suppl 1:S95-7. doi: 10.1007/s10072-012-1050-9. Review.

PMID:
22644180

Supplemental Content

Loading ...
Support Center